Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

NCT01937117 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

PROCEDURE: Positron emission tomography (PET)
DRUG: Trastuzumab
DRUG: Pertuzumab

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]